New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
11:16 EDTNAO, SVU, SD, QEP, ACT, C, KKR, GLPICooperman lists Actavis, Citigroup, KKR among top-picks, CNBC says
Leon Cooperman of Omega Advisors listed Actavis (ACT), Citigroup (C), KKR (KKR), Gaming and Leisure Properties (GLPI), Nordic American Offshore (NAO) and SuperValu (SVU), QEP Resources (QEP) and SandRidge Energy (SD) among his top stock picks while presenting at the "Delivering Alpha" conference, according to CNBC.
News For ACT;C;KKR;GLPI;NAO;SVU;SD;QEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 22, 2014
10:15 EDTACTOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Actavis (ACT) downgraded to Equal Weight from Overweight at Barclays... Aetna (AET) downgraded to Neutral from Buy at BofA/Merrill... Auxilium (AUXL) downgraded to Hold from Buy at Stifel... CARBO Ceramics (CRR) downgraded to Neutral from Buy at Sterne Agee... Commerzbank (CRZBY) downgraded to Underperform from Neutral at Exane BNP Paribas... Concur (CNQR) downgraded to Neutral from Buy at Nomura... Dresser-Rand (DRC) downgraded to Neutral from Accumulate at Global Hunter... Finish Line (FINL) downgraded to Equal Weight from Overweight at Morgan Stanley... General Communications (GNCMA) downgraded to Hold from Buy at Drexel Hamilton... InvenSense (INVN) downgraded to Neutral from Outperform at RW Baird... Las Vegas Sands (LVS) downgraded to Market Perform from Outperform at Wells Fargo... Lindsay Corp. (LNN) downgraded at Sterne Agee... Melco Crown (MPEL) downgraded to Market Perform from Outperform at Wells Fargo... Outerwall (OUTR) downgraded to Sell from Neutral at B. Riley... PSEG (PEG) downgraded to Hold from Buy at Jefferies... Realogy (RLGY) downgraded to Underperform from Neutral at Credit Suisse... Regal-Beloit (RBC) downgraded to Accumulate from Buy at Global Hunter... SABMiller (SBMRY) downgraded to Market Perform from Outperform at Bernstein... Saba Software (SABA) downgraded to Neutral from Buy at B. Riley... Suburban Propane (SPH) downgraded to Market Perform from Outperform at Wells Fargo... Swiss Re (SSREY) downgraded to Underperform from Neutral at Exane BNP Paribas... Towers Watson (TW) downgraded to Buy from Conviction Buy at Goldman... Valmont (VMI) downgraded at Sterne Agee... Walgreen (WAG) downgraded to Equal Weight from Overweight at Barclays... Watts Water (WTS) downgraded to Neutral from Buy at Janney Capital... Wynn Resorts (WYNN) downgraded to Market Perform from Outperform at Wells Fargo... Yahoo (YHOO) downgraded to Neutral from Buy at BofA/Merrill.
09:38 EDTCActive equity options trading on open
Subscribe for More Information
08:10 EDTACTActavis multiple expansion case 'compelling,' says JPMorgan
Subscribe for More Information
05:52 EDTACTActavis downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
September 20, 2014
21:15 EDTCCitigroup and Argentina's appeal on bond case dismissed, Reuters says
Subscribe for More Information
September 19, 2014
14:18 EDTACTAkorn competition settlement over VersaPharm deal approved by FTC
Subscribe for More Information
11:14 EDTCSumitomo Mitsui, Mitsubishi UFJ on short list for Citigroup unit, WSJ reports
Sumitomo Mitsui Financial Group (SMFG), Sumitomo Mitsui Trust Holding, Mitsubishi UFJ Financial (MTU) and Shinsei Bank have been shortlisted by Citigroup (C) as buyers for the U.S. bank's retail bank in Japan, the Wall Street Journal reports, citing sources. Citi could pick a buyer for the unit by the end of the year or early next year. Citigroup could sell its Diners Club branded credit card unit in Japan along with the retail bank, a source says. Reference Link
09:37 EDTCActive equity options trading on open
Subscribe for More Information
07:17 EDTCCitigroup up against hard situation in Argentina bond plea, Reuters says
Subscribe for More Information
06:42 EDTKKRKKR purchases extra 10% stake in Tiga Pilar, Reuters says
Subscribe for More Information
September 18, 2014
14:08 EDTCBanks look to high-interest personal loans to boost revenue, WSJ says
Subscribe for More Information
07:34 EDTKKRSodaStream rumored as target for SABMiller, Diageo, Independent says
Rumors haver circulated among U.K. traders that soda machine maker SodaStream (SODA) could be targeted for a takeover by beverage makers SABMiller (SBMRY) and Diageo (DEO) or private equity group KKR (KKR), according to The Independent. Reference Link
07:17 EDTKKRBMO Capital to hold a conference
14th Annual Back to School Education Conference to be held in New York on September 18 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link
06:02 EDTNAONAO chairman says company in 'excellent position to grow accretively'
In a letter to shareholders, Nordic American Offshore chairman Herbjørn Hansson said, "NAO is in an excellent position to grow accretively. After an acquisition of vessels the company shall be able to pay a higher dividend per share and produce higher earnings per share than had such acquisitions not taken place. We are actively looking for acquisition opportunities that fit in with our high-specification fleet. I am hopeful that NAO will grow significantly in the coming years while generating strong total returns."
September 17, 2014
16:18 EDTACTDepomed says FDA recognizing 7 years orphan-drug exclusivity for Gralise in PHN
Depomed (DEPO) disclosed in a filing that on September 16 the company received a letter from the FDA informing the company that pursuant to the order issued on September 5 by a judge of the U.S. District Court for the District of Columbia, the FDA is recognizing seven years of orphan-drug exclusive approval for the company’s Gralise for the management of postherpetic neuralgia. The letter also confirms the FDA will not approve any abbreviated New Drug Application referencing Gralise during the period of orphan-drug exclusive approval, which began on January 28, 2011. The FDA has 60 days after issuance of the order in Depomed, Inc. v. HHS to file a notice appealing the order to the United States Court of Appeals for the Federal Circuit. The period of orphan drug exclusivity applicable to Gralise for PHN is separate from marketing exclusivity arising from the previously disclosed decision issued on August 19 in the company’s patent litigation lawsuit against Actavis (ACT) related to an ANDA filed by Actavis seeking to market generic versions of Gralise. The decision found that Actavis infringed all seven of the company’s patents asserted in the litigation, upheld the validity of the patents and enjoined FDA approval of the Actavis ANDA until February 26, 2024, the latest expiration date of the infringed patents. On September 15, Actavis filed a notice appealing the decision to the United States Court of Appeals for the Federal Circuit, Depomed stated. Previously disclosed settlement agreements between the Company and two other Gralise ANDA filers permit the sale of generic Gralise beginning on January 1, 2024.
13:16 EDTCHolder says DOJ looking to charge bank executives, Washington Post says
Subscribe for More Information
11:25 EDTKKRKKR management to meet with Oppenheimer
Subscribe for More Information
11:01 EDTACTActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
09:16 EDTACTActavis Namenda sales of $990M could be at risk, says BMO Capital
Subscribe for More Information
09:06 EDTACTNew York AG files antitrust lawsuit against Actavis
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use